Clinical progress of diagnostic and evaluation criteria for liver transplantation in patients with severe liver disease

Jia Yanan; Li Han; Li Xianliang; He Qiang

doi:10.3969/j.issn.1674-7445.2020.03.002

Volume 11 Issue 3

May 2020

Turn off MathJax

Article Contents

Article Navigation > ORGAN TRANSPLANTATION > 2020 > 11(3): 326-332，368

Jia Yanan, Li Han, Li Xianliang, et al. Clinical progress of diagnostic and evaluation criteria for liver transplantation in patients with severe liver disease[J]. ORGAN TRANSPLANTATION, 2020, 11(3): 326-332，368. doi: 10.3969/j.issn.1674-7445.2020.03.002

Citation:

PDF( 762 KB)

Clinical progress of diagnostic and evaluation criteria for liver transplantation in patients with severe liver disease

doi: 10.3969/j.issn.1674-7445.2020.03.002

Department of Hepatobiliary-pancreatic-splenic Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China

More Information

Corresponding author: Li Xianliang,Email:lixianliangbjcy@126.com; He Qiang,Email: heqiang349@sina.com
Received Date: 2020-02-15
Available Online: 2021-01-19
Publish Date: 2020-05-15

Abstract

Abstract

Liver transplantation, although recognized as the only effective radical treatment for severe liver disease, might be accompanied by high surgical risks, high perioperative mortality and high postoperative complications. Considering the shortage of donor liver and related surgical risks, it is necessary to strictly control the indication of operation and the opportunity of transplantation. Therefore, accurate diagnosis and comprehensive evaluation of the condition of patients with severe liver disease to be treated by liver transplantation is an important part in determining the treatment plan. At present, there are many evaluation criteria for severe liver disease. In addition to the classic ChildTurcotte-Pugh (CTP) score and model for end-stage liver disease (MELD) score, many other evaluation criteria have also been developed. All transplant centers have their own choices and thus there is no uniform diagnostic criterion, with disputes among various criteria, which is exactly what this paper aims to summarize.
- Severe liver disease,
- Liver failure,
- Scoring system,
- Liver transplantation,
- Diagnostic criteria,
- Evaluation criteria,
- Child-Turcotte-Pugh (CTP) score,
- Model for end-stage liver disease (MELD) score

FullText(HTML)

References(40)

References

[1]	FORTUNE BE, GARCIA-TSAO G, CIARLEGLIO M, et al. Child-Turcotte-Pugh class is best at stratifying risk in variceal hemorrhage: analysis of a US multicenter prospective study[J]. J Clin Gastroenterol, 2017, 51(5): 446-453. DOI: 10.1097/MCG.0000000000000733.
[2]	KAPLAN DE, DAI F, SKANDERSON M, et al. Recalibrating the Child-Turcotte-Pugh score to improve prediction of transplant-free survival in patients with cirrhosis[J]. Dig Dis Sci, 2016, 61(11):3309-3320. DOI: 10.1007/s10620-016-4239-6.
[3]	姚运海, 甘建和, 赵卫峰.4种评分系统对肝硬化合并感染患者预后的评估价值[J].临床肝胆病杂志, 2019, 35(1):87-91. DOI: 10.3969/j.issn.1001-5256.2019.01.016. YAO YH, GAN JH, ZHAO WF. Value of four scoring systems in evaluating the prognosis of cirrhotic patients with infection[J]. J Clin Hepatol, 2019, 35(1):87-91. DOI: 10.3969/j.issn.1001-5256.2019.01.016.
[4]	MALINCHOC M, KAMATH PS, GORDON FD, et al.A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts[J]. Hepatology, 2000, 31(4):864-871. DOI: 10.1053/he.2000.5852.
[5]	KAMATH PS, KIM WR, Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD)[J]. Hepatology, 2007, 45(3):797-805. DOI: 10.1002/hep.21563.
[6]	ARTZNER T, MICHARD B, BESCH C, et al. Liver transplantation for critically ill cirrhotic patients: overview and pragmatic proposals[J]. World J Gastroenterol, 2018, 24(46):5203-5214. DOI: 10.3748/wjg.v24.i46.5203.
[7]	BIGGINS SW. Futility and rationing in liver retransplantation: when and how can we say no?[J]. J Hepatol, 2012, 56(6):1404-1411. DOI: 10.1016/j.jhep. 2011.11.027.
[8]	PENG Y, QI X, GUO X. Child-Pugh Versus MELD score for the assessment of prognosis in liver cirrhosis: a systematic review and Meta-analysis of observational studies[J]. Medicine (Baltimore), 2016, 95(8):e2877. DOI: 10.1097/MD.0000000000002877.
[9]	韩怡, 胡乃中. MELD、MESO、iMELD对失代偿期肝硬化患者短期预后的评估价值[J].中国现代医学杂志, 2018, 28(16):113-116. DOI: 10.3969/j.issn.1005-8982.2018. 16.023. HAN Y, HU NZ. Value of MELD, MESO and iMELD in evaluation of short-term prognosis of patients with decompensated liver cirrhosis[J]. Chin J Mod Med, 2018, 28(16):113-116. DOI: 10.3969/j.issn.1005-8982.2018. 16.023.j.issn.1005-8982.2018.16.023.
[10]	KIM WR, BIGGINS SW, KREMERS WK, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list[J]. N Engl J Med, 2008, 359(10):1018-1026. DOI: 10.1056/NEJMoa0801209.
[11]	RUF AE, KREMERS WK, CHAVEZ LL, et al. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone[J]. Liver Transpl, 2005, 11(3):336-343. DOI: 10.1002/lt.20329.
[12]	舒梦妮, 李树臣.血清钠对肝硬化失代偿期患者并发症的影响[J].肝脏, 2016, 21(1):6-8. DOI: 10.3969/j. issn.1008-1704.2016.01.003. SHU MN, LI SC. Effect of serum sodium on complications in patients with decompensated liver cirrhosis[J]. Chin Hepatol, 2016, 21(1):6-8. DOI: 10.3969/j.issn. 1008- 1704.2016.01.003.
[13]	陈培鸿, 付淑红.血清钠终末期肝病模型(MELD-Na)评分对肝硬化患者血脂和短期预后的作用分析[J].临床合理用药杂志, 2019, 12(17):121-122. DOI: 10.15887/j. cnki.13-1389/r.2019.17.080. CHEN PH, FU SH. Effect analysis of serum sodium in model for end-stage liver disease (MELD-Na) score on blood lipid and short-term prognosis in patients with liver cirrhosis[J]. Chin J Clin Rational Drug Use, 2019, 12(17):121-122. DOI: 10.15887/r.2019.17.080.
[14]	HUO TI, WANG YW, YANG YY, et al. Model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis[J]. Liver Int, 2007, 27(4):498-506. DOI: 10.1111/j.1478- 3231.2007.01445.x.
[15]	龙骏, 林世德, 刘璐璐, 等. MELD相关评分模型对重症化慢性乙型肝炎患者进展为肝衰竭的预测价值[J].中国医学创新, 2019, 16(33):153-157. DOI: 10.3969/j. issn.1674-4985.2019.33.039. LONG J, LIN SD, LIU LL, et al. Predictive value of MELD-based models for liver failure in patients with acute exacerbation of chronic hepatitis B patients[J]. Med Innov Chin, 2019, 16(33):153-157. DOI: 10.3969/j.issn.1674-4985.2019.33.039.
[16]	吴吉圆, 张冬琴, 刘菲菲, 等.病毒性肝炎肝硬化失代偿期患者评分系统对短期预后的分析[J/CD].中国肝脏病杂志(电子版), 2017, 9(1):54-60.DOI: 10.3969/j.issn.1674-7380.2017.01.012. WU JY, ZHANG DQ, LIU FF, et al. Assessment of score systems for short-term prognosis of patients with hepatitis virus-related decompensated cirrhosis[J/CD]. Chin J Liver Dis (Electr Vers), 2017, 9(1):54-60. DOI: 10.3969/j.issn.1674-7380.2017.01.012.j.issn.1674-7380.2017.01.012.
[17]	张志华, 巩晓欢, 韩永荣, 等. Child-Pugh、MELD、MELD-Na和iMELD评分对乙型肝炎肝硬化患者3个月和1年生存率的评估价值[J].胃肠病学, 2018, 23(1):24-28. DOI: 10.3969/j.issn.1008-7125.2018.01.006. ZHANG ZZ, GONG XH, HAN YR, et al. Predictive Value of Child-Pugh, MELD, MELD-Na and iMELD score in assessing 3-month and 1-year survival rates in patients with hepatitis B cirrhosis[J]. Chin J Gastroenter, 2018, 23(1):24-28. DOI: 10.3969/j.issn.1008-7125.2018.01.006.
[18]	陈铿, 曹欣, 郑茵, 等.MELD-Na与CTP评分评估乙型肝炎慢加急性肝衰竭短期预后的对比研究[J].中华肝脏病杂志, 2014, 22(11):801-805. DOI: 10.3760/cma.j.issn.1007-3418.2014.11.001. cma.j.issn.1007-3418.2014.11.001. CHEN K, CAO X, ZHENG Y, et al. Comparative study of the MELD-Na and Child-Turcotte-Pugh scores as shortterm prognostic indicators of acute-on-chronic hepatitis B liver failure[J]. Chin J Hepatol, 2014, 22(11):801-805. DOI: 10.3760/cma.j.issn.1007-3418.2014.11.001.
[19]	SALDAÑA RS, SCHREM H, BARTHOLD M, etal. Prognostic abilities and quality assessment of models for the prediction of 90-day mortality in liver transplant waiting list patients[J]. PLoS One, 2017, 12(1):e0170499. DOI: 10.1371/journal.pone.0170499.
[20]	ANNAMALAI A, HARADA MY, CHEN M, et al. Predictors of mortality in the critically ill cirrhotic patient: is the model for end-stage liver disease enough?[J]. J Am Coll Surg, 2017, 224(3):276-282. DOI: 10.1016/j.jamcollsurg.2016.11.005.
[21]	姜明建, 范蔚芳, 林淑媛.人工肝血浆置换联合血液滤过对妊娠中晚期重症肝病患者临床指标和生存率的影响[J].肝脏, 2018, 23(10):892-894. DOI: 10.3969/j.issn.1008-1704.2018.10.016. JIANG MJ, FAN WF, LIN SY. Effect of artificial liver plasma exchange combined with hemofiltration on clinical indexes and survival rate of patients with severe liver disease in the middle and late pregnancy[J]. Chin Hepatol, 2018, 23(10):892-894. DOI: 10.3969/j.issn.1008-1704.2018.10.016.
[22]	胡月云, 刘波普, 颜君, 等. APACHE Ⅳ评分和MELD评分对肝移植术后患者死亡分辨能力研究[J/CD].中华肝脏外科手术学电子杂志, 2013, 2(5): 314-317. DOI: 10.3877/cma.j.issn.2095-3232.2013.05.010. HU YY, LIU BP, YAN J, et al. Discriminability of acute physiology and chronic health evaluation Ⅳ and model for end-stage liver disease scores on mortality after liver transplantation[J/CD]. Chin J Hepatic Surg (Electr Edit), 2013, 2(5): 314-317. DOI: 10.3877/cma.j.issn.2095-3232.2013.05.010.
[23]	MCPHAIL MJ, FARNE H, SENVAR N, et al. Ability of King's College criteria and model for end-stage liver disease scores to predict mortality of patients with acute liver failure: a Meta-analysis[J]. Clin Gastroenterol Hepatol, 2016, 14(4):516-525. DOI: 10.1016/j.cgh.2015. 10.007.
[24]	韩璞青, 孙嫣. MELD、MELD-Na评分及KCH标准对妊娠期急性肝衰竭患者预后的评估价值[J].临床肝胆病杂志, 2018, 34(7):1508-1513. DOI: 10.3969/j.issn.1001-5256.2018.07.028. issn.1001-5256.2018.07.028. HAN PQ, SUN Y. Value of MELD score, MELD-Na score, and King's College Hospital criteria in evaluating the prognosis of patients with acute liver failure of pregnancy[J].J Clin Hepatol, 2018, 34(7):1508-1513. DOI: 10.3969/j.issn.1001-5256.2018.07.028.
[25]	BERNAL W, WILLIAMS R. Beyond KCH selection and options in acute liver failure[J]. Hepatol Int, 2018, 12(3):204-213. DOI: 10.1007/s12072-018-9869-7.
[26]	BAILEY B, AMRE DK, GAUDREAULT P. Fulminant hepatic failure secondary to acetaminophen poisoning: a systematic review and Meta-analysis of prognostic criteria determining the need for liver transplantation[J]. Crit Care Med, 2003, 31(1):299-305. DOI: 10.1097/00003246- 200301000-00048.
[27]	丁蕊, 赵红, 闫杰, 等.慢加急性肝衰竭的定义及治疗进展[J/CD].中国肝脏病杂志(电子版), 2018, 10(1): 1-5. DOI: 10.3969/j.issn.1674-7380.2018.01.001. DING R, ZHAO H, YAN J, et al. Defination and treatment progress of acute-on-chronic liver failure [J/CD]. Chin J Liver Dis (Electr Vers), 2018, 10(1): 1-5. DOI: 10.3969/j.issn.1674-7380.2018.01.001.
[28]	DUSEJA A, CHOUDHARY NS, GUPTA S, et al. APACHE Π score is superior to SOFA, CTP and MELD in predicting the short-term mortality in patients with acute-on-chronic liver failure (ACLF)[J]. J Dig Dis, 2013, 14(9):484-490. DOI: 10.1111/1751-2980.12074.
[29]	ZHOU XD, CHEN QF, WANG ZX, et al. Acute circulatory failure-chronic liver failure-sequential organ failure assessment score: a novel scoring model for mortality risk prediction in critically ill cirrhotic patients with acute circulatory failure[J]. Eur J Gastroenterol Hepatol, 2017, 29(4):464-471. DOI: 10.1097/MEG.0000000000000817.
[30]	SUN DQ, ZHENG CF, LIU WY, et al. AKI-CLIF-SOFA: a novel prognostic score for critically ill cirrhotic patients with acute kidney injury[J]. Aging (Albany NY), 2017, 9(1):286-296. DOI: 10.18632/aging.101161.
[31]	DIRCHWOLF M, RUF AE. Role of systemic inflammation in cirrhosis: from pathogenesis to prognosis[J]. World J Hepatol, 2015, 7(16):1974-1981. DOI: 10.4254/wjh.v7.i16.1974.
[32]	陈卉, 谭诗云. MELD评分联合NLR预测肝硬化患者短期预后的价值[J].医学研究杂志, 2019, 48(5):143- 147. DOI: 10.11969/j.issn.1673-548X.2019.05.034. CHEN H, TAN SY. Value of MELD score combined with NLR in predicting the short-term prognosis of patients with liver cirrhosis[J]. J Med Res, 2019, 48(5):143-147. DOI: 10.11969/j.issn.1673-548X.2019.05.034.
[33]	杨君, 黄洋辉.血清MMP-2, AFP与MELD评分对HBV相关慢加急性肝衰竭患者预后的评估价值[J].临床与病理杂志, 2019, 39(8):1648-1653. DOI: 10.3978/j. issn.2095-6959.2019.08.006. YANG J, HUANG YH. Value of serum MMP-2, AFP and MELD score in prognosis assessment of patients with HBV-related acute on chronic liver failure[J]. Int J Pathol Clin Med, 2019, 39(8):1648-1653. DOI: 10.3978/j.issn.2095-6959.2019.08.006.
[34]	PINATO DJ, SHARMA R, ALLARA E, et al. The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma[J]. J Hepatol, 2017, 66(2):338-346. DOI: 10.1016/j.jhep.2016.09.008.
[35]	HIRAOKA A, KUMADA T, KUDO M, et al. AlbuminBilirubin (ALBI) grade as part of the evidence-based clinical practice guideline for HCC of the Japan society of hepatology: a comparison with the liver damage and Child-Pugh classifications[J]. Liver Cancer, 2017, 6(3):204-215. DOI: 10.1159/000452846.
[36]	吴坤亮, 张英, 黄晶, 等.终末期肝病模型评分联合吲哚菁绿清除实验预测HBV相关慢加急性肝衰竭预后[J].中山大学学报(医学版), 2018, 39(6):935-940. http://d.old.wanfangdata.com.cn/Periodical/zsykdxxb201806020 WU KL, ZHANG Y, HUANG J, et al. Model for endstage liver disease combined with indocyanine green clearance test can effectively predict the prognosis of HBV-associated acute-on-chronic liver failure[J]. J Sun Yat-sen Univ (Med Sci), 2018, 39(6):935-940. http://d.old.wanfangdata.com.cn/Periodical/zsykdxxb201806020
[37]	吕佳昱, 韩涛.关注重症肝病临床管理的热点问题[J].临床肝胆病杂志, 2017, 33(9):1617-1620. DOI: 10.3969/j.issn.1001-5256.2017.09.001. LYU JY, HAN T. Hotspots in clinical management of severe liver diseases[J]. J Clin Hepatol, 2017, 33(9):1617- 1620. DOI: 10.3969/j.issn.1001-5256.2017.09.001.
[38]	JASSERON C, FRANCOZ C, ANTOINE C, et al. Impact of the new MELD-based allocation system on waiting list and post-transplant survival - a cohort analysis using the French national CRISTAL database[J]. Transpl Int, 2019, DOI: 10.1111/tri.13448 [Epubahead of print].
[39]	PARIKH ND, AGOPIAN VG. Moving toward personalizing MELD exceptions in liver transplantation for hepatocellular carcinoma[J]. Am J Transplant, 2019, 19(8):2153-2154. DOI: 10.1111/ajt.15389.
[40]	GINÈS P, FERNÁNDEZ J, DURAND F, et al. Management of critically-ill cirrhotic patients[J]. J Hepatol, 2012, 56 (Suppl 1):S13-S24. DOI: 10.1016/S0168-8278(12)60003-8.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (196) PDF downloads(23)

Clinical progress of diagnostic and evaluation criteria for liver transplantation in patients with severe liver disease

doi: 10.3969/j.issn.1674-7445.2020.03.002

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Clinical progress of diagnostic and evaluation criteria for liver transplantation in patients with severe liver disease

doi: 10.3969/j.issn.1674-7445.2020.03.002

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Export File

Citation

Format

Content